Search

Author/Creator Fee, Dominic

1. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial. Issue 10 (October 2021)

Authors:
Cudkowicz, Merit; Genge, Angela; Maragakis, Nicholas; Petri, Susanne; van den Berg, Leonard; Aho, Valtteri V; Sarapohja, Toni; Kuoppamäki, Mikko; Garratt, Chris; Al-Chalabi, Ammar; Kiernan, Matthew; Mathers, Susan; Henderson, Robert; Needham, Merrilee; Schultz, David; Löscher, Wolfgang; Mitrovic,...
Journal:
Lancet neurology
Issue:
Volume 20:Issue 10(2021)
Page Start:
821
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. Issue 3 (3rd April 2021)

Authors:
Shefner, Jeremy M.; Andrews, Jinsy A.; Genge, Angela; Jackson, Carlayne; Lechtzin, Noah; Miller, Timothy M.; Cockroft, Bettina M.; Meng, Lisa; Wei, Jenny; Wolff, Andrew A.; Malik, Fady I.; Bodkin, Cynthia; Brooks, Benjamin R.; Caress, James; Dionne, Annie; Fee, Dominic; Goutman, Stephen A.; Goyal...
Journal:
Amyotrophic lateral sclerosis and frontotemporal degeneration
Issue:
Volume 22:Issue 3/4(2021)
Page Start:
287
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗